Evidence on benefits, risks, and costs

Author(s)

• United States. Congress. Office of Technology Assessment

Bibliographic Information

Evidence on benefits, risks, and costs

（Effectiveness and costs of osteoporosis screening and hormone replacement therapy, v. 2）（Background paper / United States. Office of Technology Assessment）

Office of Technology Assessment, Congress of the U.S. , For sale by the U.S. G.P.O., Supt. of Docs., [1995]

Access to Electronic Resource 3 items

• Effectiveness and costs of osteoporosis screening and hormone replacement therapy. (v. 2)

  1995

  HathiTrust

  

• Effectiveness and costs of osteoporosis screening and hormone replacement therapy. (v.1)

  1995

  HathiTrust

  

• Effectiveness and costs of osteoporosis screening and hormone replacement therapy. (v.2*)

  1995

  HathiTrust

  

Note

"August 1995--P. [4] of cover

"OTA-BP-H-144"--P. [4] of cover

Includes bibliographical references

Details

• NCID: BA53476895
• ISBN:
  • 0160482089
• LCCN: 95219829
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: Washington, D.C.,Washington, D.C.
• Pages/Volumes: x, 229 p.
• Size: 28 cm
• Classification:
  • LCC : RC931.O73
  • DC20 : 362.1/96716
• Subject Headings:
  • LCSH : Osteoporosis -- United States
  • LCSH : Medical screening -- United States
  • LCSH : Osteoporosis -- Treatment -- United States
  • LCSH : Osteoporosis -- Hormone therapy -- United States
• Parent Bibliography ID:
  • BA53476545
  • BA26155913